<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03691883</url>
  </required_header>
  <id_info>
    <org_study_id>STAGE-TB</org_study_id>
    <nct_id>NCT03691883</nct_id>
  </id_info>
  <brief_title>Design of an Integrative Algorithm for Staging Tuberculosis</brief_title>
  <acronym>STAGE-TB</acronym>
  <official_title>Design of an Integrative Algorithm for Staging Tuberculosis to Improve Clinical Management.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut Germans Trias i Pujol</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitari Vall d'Hebron (Drassanes)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Servicios Clínicos de Barcelona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Germans Trias i Pujol Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Sant Joan de Deu</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital del Mar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundació Institut Germans Trias i Pujol</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tuberculosis is a chronic infectious disease that affects 10 million people, 300 in the city
      of Barcelona, every year. With serious consequences at public health level, it is associated
      with other diseases, and generated and influenced by many social and psychological factors.
      This study aims to stage tuberculosis disease by an integrative approach.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tuberculosis is a chronic infectious disease that affects 10 million people, there are 300
      new cases 300 in the city of Barcelona, every year. Tuberculosis has serious consequences at
      public health level. It is associated with other diseases, and generated and influenced by
      many social and psychological factors. This study aims to stage tuberculosis disease by a
      novel integrative approach.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 19, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Clinical changes</measure>
    <time_frame>timepoints 0 (at inclusion), at month 2 and month 6 (and month 12 if MDR/XDR)</time_frame>
    <description>Changes in clinical status</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Microbiological changes</measure>
    <time_frame>timepoints 0 (at inclusion), at month 2 and month 6 (and month 12 if MDR/XDR)</time_frame>
    <description>Changes in microbiological cultures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in Biomarkers values</measure>
    <time_frame>timepoints 0 (at inclusion), at month 2 and month 6 (and month 12 if MDR/XDR)</time_frame>
    <description>Changes in the biomarkers along time assessed by using analyzing parameters in blood and urine samples (by ELISA and LUMINEX)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological Score Value</measure>
    <time_frame>timepoints 0 (at inclusion), at month 2 and month 6 (and month 12 if MDR/XDR)</time_frame>
    <description>Changes in the BCN-SA Radiological Score Value. This Score assesses the sum of acute and chronic findings in the chest X-ray. Per each finding, a maximum score of 8 is recorded. The total score value is calculated by adding all the individual findings score values. Higher values of total score represent a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in SGRQ score</measure>
    <time_frame>timepoints 0 (at inclusion), at month 2 and month 6 (and month 12 if MDR/XDR)</time_frame>
    <description>Changes in Health Quality of Life measures along time assessed by using the Saint George's Respiratory Questionnaire (SGRQ, numeric score). It measures 3 subscales (symptoms/activity/impacts) and The Total score is calculated by summing all positive responses in the questionnaire and expressing the result as a percentage of the total weight for the questionnaire. Higher values represent a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Kessler-10 score</measure>
    <time_frame>timepoints 0 (at inclusion), at month 2 and month 6 (and month 12 if MDR/XDR)</time_frame>
    <description>Changes in Health Quality of Life measures along time assessed by using the questionnaire Kessler-10 (K10, numeric score). Higher values represent a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Health Quality of Life measures along time using BCN-Q questionnaire</measure>
    <time_frame>timepoints 0 (at inclusion), at month 2 and month 6 (and month 12 if MDR/XDR)</time_frame>
    <description>Changes in Health Quality of Life measures along time using BCN-Q questionnaire (descriptive questionnaire).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Tuberculosis</condition>
  <arm_group>
    <arm_group_label>TB patients</arm_group_label>
    <description>TB patients diagnosed and followed-up in Barcelona, at the following Hospitals/Clinics: Servicios Clínicos, Hospital Universitari Germans Trias i Pujol, Hospital Universitari Vall d'Hebron-Drassanes, Hospital del Mar.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Bloood samples for determination of DNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        TB patients which clinical management is done at the following clinical centers: Servicios
        Clínicos, Hospital Universitari Vall d'Hebron-Drassanes or Hospital Universitari Germans
        Trias i Pujol.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  TB diagnosis (all forms), microbiologically confirmed (by AFB+, GenXpert+ or Culture+)

          -  Clinical management of the patients being done at Servicios Clínicos, Hospital
             Universitari Vall d'Hebron-Drassanes or Hospital Universitari Germans Trias i Pujol.

        Exclusion Criteria:

          -  Not consenting to data/samples donation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cris Vilaplana, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundació Institut Germans Trias i Pujol</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cris Vilaplana, MD, PhD</last_name>
    <phone>934978677</phone>
    <email>cvilaplana@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laura Villegas</last_name>
    <phone>+34934978681</phone>
    <email>secretary.ute@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitari Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zoran Stojanovic, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Cristina Prat, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zoran Stojanovic, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Sant Joan de Déu</name>
      <address>
        <city>Esplugues De Llobregat</city>
        <state>Barcelona</state>
        <zip>08950</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoni Noguera, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Antoni Noguera, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neus Jové, MD</last_name>
    </contact>
    <investigator>
      <last_name>Neus Jové, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francisca Sánchez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marisol Domínguez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Núria López, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Vall d'Hebron-Drassanes</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrián Sánchez, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Adrián Sánchez, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Malú De Souza, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jiménez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pere Soler, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Martín, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antoni Soriano, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Teresa Tórtola, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Israel Molina, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Núria Saborit</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Servicios Clínicos de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Pau Millet</last_name>
    </contact>
    <investigator>
      <last_name>Joan Pau Millet, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xavier Casas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Israel Molina, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gónzalez-Díaz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maldonado, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Altet, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jaume Ollé-Goig, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Núria Forcades, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://unitatdetuberculosiexperimental.wordpress.com</url>
    <description>This is the web site of the research group</description>
  </link>
  <results_reference>
    <citation>Pujol-Cruells A, Vilaplana C. Specific Interventions for Implementing a Patient-Centered Approach to TB Care in Low-Incidence Cities. Front Med (Lausanne). 2019 Nov 26;6:273. doi: 10.3389/fmed.2019.00273. eCollection 2019.</citation>
    <PMID>31850353</PMID>
  </results_reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 3, 2017</study_first_submitted>
  <study_first_submitted_qc>September 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 2, 2018</study_first_posted>
  <last_update_submitted>January 20, 2020</last_update_submitted>
  <last_update_submitted_qc>January 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tuberculosis, infectious diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>IPD that underlie results in a publication might be shared with other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

